Sunmax Biotechnology Co., Ltd. 4728.TWO Stock
Sunmax Biotechnology Co., Ltd. Price Chart
Sunmax Biotechnology Co., Ltd. 4728.TWO Financial and Trading Overview
Sunmax Biotechnology Co., Ltd. stock price | 232 TWD |
Previous Close | 209 TWD |
Open | 211 TWD |
Bid | 206 TWD x 0 |
Ask | 208 TWD x 0 |
Day's Range | 205.5 - 214 TWD |
52 Week Range | 116.5 - 300 TWD |
Volume | 122.51K TWD |
Avg. Volume | 340.03K TWD |
Market Cap | 11.44B TWD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 21.66141 |
EPS (TTM) | 11.47 TWD |
Forward Dividend & Yield | 4.4 (2.13%) |
Ex-Dividend Date | July 13, 2022 |
1y Target Est | N/A |
4728.TWO Valuation Measures
Enterprise Value | 11.22B TWD |
Trailing P/E | 21.66141 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 8.465522 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Sunmax Biotechnology Co., Ltd. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 74.89% |
S&P500 52-Week Change | 20.43% |
52 Week High | 300 TWD |
52 Week Low | 116.5 TWD |
50-Day Moving Average | 230.39 TWD |
200-Day Moving Average | 162.56 TWD |
4728.TWO Share Statistics
Avg. Volume (3 month) | 340.03K TWD |
Avg. Daily Volume (10-Days) | 200.3K TWD |
Shares Outstanding | 54.46M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 40.03% |
% Held by Institutions | 9.25% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.45360002 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | 25.71 TWD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | 9.51 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 24.334 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Sunmax Biotechnology Co., Ltd.
Country | Taiwan |
State | N/A |
City | Tainan City |
Address | No.10, Lane 31 |
ZIP | 744 |
Phone | 886 6 505 3288 |
Website | https://www.sunmaxbiotech.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets medical-grade collagen-based medical devices in Asia. The company offers Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes; and dermal fillers, such as Sunmax collagen implant I-Plus and Sumax collagen implant I for the correction of facial defects, such as the fill up of wrinkles. It also provides Sunmax collagen dental bone graft, Sunmax collagen dental membrane, and Sunmax dental bone graft granules, which are used in the augmentation or reconstructive treatment of the alveolar ridge. In addition, the company offers Sunmax collagen bone graft matrix that provides a bone void filler that is resorbed and replaced with bone during the healing process; and skincare products comprising Sunmax 6 collagen facial cleanser, Sunmax 7 collagen essence, Sunmax 8 active collagen essence mask, Sunmax 9 collagen refining cream, Sunmax 10 collagen eye renewal cream, Sunmax 11 collagen moisturizing cream, Sunmax 15 Collagen MesoRepair, and Sunmax Collagen Peptide that are used as aftercare of dermal filler treatment. Sunmax Biotechnology Co., Ltd. was founded in 2001 and is based in Tainan City, Taiwan.
Q&A For Sunmax Biotechnology Co., Ltd. Stock
What is a current 4728.TWO stock price?
Sunmax Biotechnology Co., Ltd. 4728.TWO stock price today per share is 232 TWD.
How to purchase Sunmax Biotechnology Co., Ltd. stock?
You can buy 4728.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sunmax Biotechnology Co., Ltd.?
The stock symbol or ticker of Sunmax Biotechnology Co., Ltd. is 4728.TWO.
Which industry does the Sunmax Biotechnology Co., Ltd. company belong to?
The Sunmax Biotechnology Co., Ltd. industry is Biotechnology.
How many shares does Sunmax Biotechnology Co., Ltd. have in circulation?
The max supply of Sunmax Biotechnology Co., Ltd. shares is 54.46M.
What is Sunmax Biotechnology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Sunmax Biotechnology Co., Ltd. PE Ratio is 20.22667700 now.
What was Sunmax Biotechnology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Sunmax Biotechnology Co., Ltd. EPS is 11.47 TWD over the trailing 12 months.
Which sector does the Sunmax Biotechnology Co., Ltd. company belong to?
The Sunmax Biotechnology Co., Ltd. sector is Healthcare.